RESMED INC — Director's Dealing 2021

Nov 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-10

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-10	ResMed Common Stock	M	2500	$57.76	Acquired	87333	Direct
2021-11-10	ResMed Common Stock	S	2500	$260.58	Disposed	84833	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-10	ResMed Common Stock Options	$57.76	M	2500	Disposed	2023-11-16	ResMed Common Stock (2500)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Includes 46.9876 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.

F3: Represents date options first became exercisable. Options vest 1/3 per year.